<DOC>
	<DOCNO>NCT02682394</DOCNO>
	<brief_summary>Prognostic Importance Quantitative Magnetic Resonance Imaging Evaluation Pancreatic Steatosis Patients Pancreatic Cancer</brief_summary>
	<brief_title>Evaluation Pancreatic Steatosis Patients With Cancer Pancreas</brief_title>
	<detailed_description>1 . Finding patient pancreatic cancer ( stage ) , treatment . 2 . Non invasively quantify fatty infiltration pancreas use , MRI DIXON Scan pancreatic cancer patient relatively liver . 3 . Measuring cell-free blood DNA patient evaluate aggressiveness disease . 4 . Quantify prognostic significance pancreatic steatosis comparison clinical pathological prognostic index use today .</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>patient diagnose pancreatic cancer , stage , treatment . &gt; 18 y.o claustrophobia GFR &lt; 30 patient non mri compatible device ( e.g . orthopaedic external fixation system ) After chemotherapy treatment surgical procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Cancer pancreas</keyword>
	<keyword>steatosis</keyword>
	<keyword>MRI</keyword>
</DOC>